Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 41,647 $ 58,910
Prepaid expenses 1,653 1,485
Accounts receivable from related party 663 0
Other current assets 191 19
Total current assets 44,154 60,414
Property and equipment, net 7,237 1,952
In-process research and development 26,623 26,623
Other assets 1,402 1,402
Total assets 79,416 90,391
Current liabilities:    
Accounts payable 1,283 2,517
Accrued liabilities 6,231 2,690
Current portion of long-term debt 0 2,400
Deferred revenue 5,658 2,765
Other current liabilities 104 70
Total current liabilities 13,276 10,442
Warrant liabilities 42 954
Long-term debt, net 3,063 1,078
Other liabilities 859 628
Total liabilities 17,240 13,102
Commitments and contingencies (Note 9)
Stockholders’ equity    
Common stock, $0.001 par value, shares authorized: 150,000,000 shares at June 30, 2018 and December 31, 2017; issued and outstanding: 27,065,198 shares at June 30, 2018 and 26,898,330 shares at December 31, 2017 27 27
Additional paid-in capital 144,975 141,733
Accumulated other comprehensive loss 0 0
Accumulated deficit (82,826) (64,471)
Total stockholders’ equity 62,176 77,289
Total liabilities and stockholders’ equity $ 79,416 $ 90,391